Cathay Biotech Inc. (688065.SH) stated on the investor interaction platform on September 18th that some of the long-chain diacids can be used for side chain modification of peptide drugs, providing sustained release effects. The company is also actively exploring related business opportunities and hopes to create more commercial value with its years of technical expertise in synthetic biology.
凯赛生物(688065.SH)：部分超长链二元酸品种可用于多肽类药物的侧链修饰
Cathay Biotech Inc. (688065.SH): Some varieties of super long-chain dicarboxylic acids can be used for side chain modification of peptide drugs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated